Sydney A. Gilman's Insider Trades & SAST Disclosures

Sydney A. Gilman's most recent trade in DiaMedica Therapeutics Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 28, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
DiaMedica Therapeutics Inc
Sydney A. Gilman VP, Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2021 25,000 25,000 - - Stock Option (right to buy)
DiaMedica Therapeutics Inc
Sydney A. Gilman VP, Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades